Literature DB >> 22440261

Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.

Habib Ganfon1, Joanne Bero, Alembert T Tchinda, Fernand Gbaguidi, Joachim Gbenou, Mansourou Moudachirou, Michel Frédérich, Joëlle Quetin-Leclercq.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Aerial parts of Acanthospermum hispidum D.C. are often used by traditional healers in Benin for various diseases and especially for malaria. AIM OF THE STUDY: To identify active compounds from extracts of Acanthospermum hispidum D.CV. leaves previously shown to possess antimalarial properties and analyse in vivo activity and toxicity of crude extracts.
MATERIALS AND METHODS: Compounds were isolated from aerial part of Acanthospermum hispidum D.C. and structurally elucidated using extensive spectroscopic analysis. Antiplasmodial activity was evaluated in vitro against a chloroquine-sensitive strain of Plasmodium falciparum (3D7) using the measurement of the plasmodial lactate dehydrogenase activity and in vivo against Plasmodium berghei berghei by the 4-day suppressive test. Selectivity of extract and purified compounds on Plasmodium parasites were evaluated by using MTT test on J774 macrophage like murine cells and WI38 human normal fibroblasts and also against two other parasites: Trypanosoma brucei brucei and Leishmania mexicana mexicana. Acute and sub-acute toxicities of a crude extract were evaluated on mice.
RESULTS: Two known sesquiterpenic lactones were isolated: 1 (15-acetoxy-8β-[(2-methylbutyryloxy)]-14-oxo-4,5-cis-acanthospermolide) and 2 (9α-acetoxy-15-hydroxy-8β-(2-methylbutyryloxy)-14-oxo-4,5-trans-acanthospermolide). 1 and 2 showed in vitro antiplasmodial activity against the chloroquine-sensitive strain (3D7) with IC(50) of 2.9±0.5 and 2.23±0.09μM respectively. Only 2 showed a high selectivity index (SI: 18.4) on Plasmodium compared to cytotoxicity against human fibroblasts cell line (WI38). 1 and 2 also showed interesting antiparasitic activities in vitro against Trypanosoma brucei brucei (IC(50) of 2.45±0.49 and 6.36±1.42μM respectively) and Leishmania mexicana mexicana (IC(50) of 0.94±0.05 and 2.54±0.19μM respectively). Furthermore, crude acidic water extract and fractions containing one of the two isolated compounds displayed a weak in vivo antimalarial activity against Plasmodium berghei berghei with a long half-life causing a delayed effect. In vivo acute (2000mg/kg) and sub-acute (1000mg/kg) toxicity tests on the crude acidic water extract did not show toxicity.
CONCLUSION: Crude acidic water extract, fractions and pure isolated compounds from Acanthospermum hispidum showed promising in vitro antiplasmodial activity. Despite our study did not show in vivo acute and subacute toxicities of the crude acidic water extract, its weak in vivo antimalarial activity and the in vitro cytotoxicity of pure compounds and enriched extracts containing 1 and 2 indicate that the aerial parts of Acanthospermum hispidum should be used with caution for malaria treatments.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440261     DOI: 10.1016/j.jep.2012.03.002

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

Review 1.  Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens.

Authors:  Ramesh Subramani; Mathivanan Narayanasamy; Klaus-D Feussner
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

Review 2.  Antiplasmodial natural products: an update.

Authors:  Nasir Tajuddeen; Fanie R Van Heerden
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

3.  Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.

Authors:  Cristiane França da Silva; Denise da Gama Jaen Batista; Julianna Siciliano De Araújo; Marcos Meuser Batista; Jessica Lionel; Elen Mello de Souza; Erica Ripoll Hammer; Patricia Bernardino da Silva; Maria De Mieri; Michael Adams; Stefanie Zimmermann; Matthias Hamburger; Reto Brun; Wolfgang Schühly; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

4.  Anti-plasmodial activity of Dicoma tomentosa (Asteraceae) and identification of urospermal A-15-O-acetate as the main active compound.

Authors:  Olivia Jansen; Monique Tits; Luc Angenot; Jean-Pierre Nicolas; Patrick De Mol; Jean-Baptiste Nikiema; Michel Frédérich
Journal:  Malar J       Date:  2012-08-21       Impact factor: 2.979

Review 5.  The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids.

Authors:  Pascal Amoa Onguéné; Fidele Ntie-Kang; Lydia Likowo Lifongo; Jean Claude Ndom; Wolfgang Sippl; Luc Meva'a Mbaze
Journal:  Malar J       Date:  2013-12-13       Impact factor: 2.979

Review 6.  Antiparasitic activity in Asteraceae with special attention to ethnobotanical use by the tribes of Odisha, India.

Authors:  Sujogya Kumar Panda; Walter Luyten
Journal:  Parasite       Date:  2018-03-12       Impact factor: 3.000

7.  Natural products as a source for treating neglected parasitic diseases.

Authors:  Dieudonné Ndjonka; Ludmila Nakamura Rapado; Ariel M Silber; Eva Liebau; Carsten Wrenger
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

8.  Natural terpenoids from Ambrosia species are active in vitro and in vivo against human pathogenic trypanosomatids.

Authors:  Valeria P Sülsen; Silvia I Cazorla; Fernanda M Frank; Laura C Laurella; Liliana V Muschietti; Cesar A Catalán; Virginia S Martino; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

Review 9.  Herbal Drugs from Sudan: Traditional Uses and Phytoconstituents.

Authors:  Mohamed Gamaleldin Elsadig Karar; Nikolai Kuhnert
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

Review 10.  A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.

Authors:  Johnson O Oladele; Ebenezer I Ajayi; Oyedotun M Oyeleke; Oluwaseun T Oladele; Boyede D Olowookere; Boluwaji M Adeniyi; Olu I Oyewole; Adenike T Oladiji
Journal:  Heliyon       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.